問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-04-01 - 2028-12-31
Condition/Disease
moderate to severe atopic dermatitis
Test Drug
injective
Participate Sites7Sites
Recruiting7Sites
2022-07-01 - 2030-01-22
Participate Sites6Sites
Recruiting6Sites
2019-11-01 - 2022-12-31
Participate Sites5Sites
Terminated5Sites
2009-07-01 - 2010-06-30
Participate Sites8Sites
Terminated8Sites
2009-02-27 - 2010-05-05
Participate Sites3Sites
Terminated3Sites
2020-12-15 - 2022-12-31
Participate Sites1Sites
Terminated1Sites
2021-08-30 - 2022-08-30
2017-04-01 - 2019-12-31
Participate Sites4Sites
Terminated4Sites
2021-01-04 - 2026-04-30
This is a Phase 3, open-label, trial designed to evaluate CG0070 in patients with high-grade CIS of the bladder unresponsive to Bacillus Calmette-Guerin (BCG).
CG0070 DDM
Recruiting4Sites
2022-07-01 - 2027-02-26
Not yet recruiting4Sites
全部
